ProKidney Corp.
ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular ther... Read more
Org chart
Collapse
Teams
Offices
RQI Partners, LLC
5 followers
Xilio Therapeutics
2 followers
Women In Bio - Engage. Educate. Empower.
1 follower
PROCEPT BioRobotics
5 followers
Truveta
5 followers
Unlock Health
5 followers
Adimab
1 follower
Clinion
1 follower
Microbial Discovery Group
1 follower
Anteris Technologies
2 followers
Kx Advisors
1 follower
ProcDNA
1 follower